Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Anthony Tarabay"'
Autor:
Anthony Tarabay, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, David Malka, Valérie Boige, Antoine Hollebecque, Michel Ducreux
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2569 (2023)
Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed
Externí odkaz:
https://doaj.org/article/26a3fb018c8542f2bb1c09dce554c516
Autor:
Cyril Quivoron, Anthony Tarabay, Jean-Marie Michot, Arnaud Pagès, Hélène Lecourt, Anne Aupérin, Alina Danu, Julien Lazarovici, Julien Rossignol, David Ghez, Peggy Dartigues, Véronique Vergé, Christophe Massard, Valérie Camara-Clayette, Vincent Ribrag, Clémentine Sarkozy
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/07cddb91d843474fbd7f6fa47506fa36
Autor:
Sabine Khalife-Hachem, Khalil Saleh, Florence Pasquier, Christophe Willekens, Anthony Tarabay, Leony Antoun, Thomas Grinda, Cristina Castilla-Llorente, Matthieu Duchmann, Cyril Quivoron, Nathalie Auger, Veronique Saada, Suzette Delaloge, Alexandra Leary, Aline Renneville, Ileana Antony-Debre, Filippo Rosselli, Stéphane De Botton, Flore Salviat, Christophe Marzac, Jean-Baptiste Micol
Publikováno v:
HemaSphere, Vol 5, Iss 9, p e632 (2021)
Definition of therapy-related myeloid neoplasms (TRMN) is only based on clinical history of exposure to leukemogenic therapy. No specific molecular classification combining therapy-related acute myeloid leukemia and therapy-related myelodysplastic sy
Externí odkaz:
https://doaj.org/article/49b74150c3484f2f99fdc14bfd50eb8c
Autor:
Imen Ben-Ammar, Michel Ducreux, Valérie Boige, Antoine Hollebecque, Anthony Tarabay, Cristina Smolenschi, Maximiliano Gelli, Marie Laure Tanguy, Marine Valery, Etienne Rouleau, Rémy Barbe, Alice Boileve, Alina Cristina Fuerea
Publikováno v:
Journal of Clinical Oncology. 41:750-750
750 Background: KRAS mutation is the most common molecular alteration (MA) in pancreatic adenocarcinoma (PDAC), and only 8-10% of patients (pts) harbor KRAS wild-type tumors (WT). This study describes clinical and molecular features of KRAS WT PDAC a
Autor:
Cristina Smolenschi, Marine Valery, Alice Boileve, Baptiste Cervantes, Anthony Tarabay, Valerie Boige, Imen Ben-Ammar, Bianca Cheaib, Maximiliano Gelli, Isabelle Sourouille, Leonor Benhaim, Alina Fuerea, Audrey Perret, Michel Ducreux, Antoine Hollebecque
Publikováno v:
Journal of Clinical Oncology. 41:809-809
809 Background: Peritoneal carcinomatosis (PC) is a common manifestation in gastro-intestinal (GI) cancers.10-20 % of patients (pts) will present isolated, unresectable peritoneal disease with poor prognosis. In the past years, circulating tumor DNA
Autor:
Anthony Tarabay, Antoine Hollebecque, Cristina Smolenschi, Leony Antoun, Caroline Klotz, Alina Fuerea, Audrey Perret, Claire Gouriou, Pascal Burtin, Hichem Belkhodja, Valérie Boige, David Malka, Michel Ducreux
Publikováno v:
Journal of Clinical Oncology. 40:605-605
605 Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack for treatment options. Gene alterations (GAs) are frequently
Autor:
Marcel Massoud, Leony Antoun, Jean Zeghondy, Anthony Tarabay, Nicole Nourie, Fadi Nasr, Georges Chahine
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S284
Autor:
Boilève, Alice1,2,3 (AUTHOR) alice.boileve@gustaveroussy.fr, Smolenschi, Cristina1,4 (AUTHOR) valerie.boige@gustaveroussy.fr, Lambert, Aurélien5 (AUTHOR) a.lambert@nancy.unicancer.fr, Boige, Valérie1 (AUTHOR) matthieu.delaye@gustaveroussy.fr, Delaye, Matthieu1 (AUTHOR) geraldine.camilleri@gustaveroussy.fr, Camilleri, Géraldine M.1 (AUTHOR) anthony.tarabay@gustaveroussy.fr, Tarabay, Anthony1 (AUTHOR) marine.valery@gustaveroussy.fr, Valéry, Marine1 (AUTHOR) alinacristina.fuerea@gustaveroussy.fr, Fuerea, Alina1 (AUTHOR) thomas.pudlarz@gustaveroussy.fr, Pudlarz, Thomas1 (AUTHOR) antoine.hollebecque@gustaveroussy.fr, Mathieu, Jacques R. R.2,3 (AUTHOR) fanny.jaulin@gustaveroussy.fr, Jaulin, Fanny2,3 (AUTHOR), Hollebecque, Antoine1,4 (AUTHOR) michel.ducreux@gustaveroussy.fr, Ducreux, Michel1,2 (AUTHOR)
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 20, p3455. 16p.
Autor:
Valery, Marine1 (AUTHOR) alice.boileve@gustaveroussy.fr, Vasseur, Damien2 (AUTHOR) damien.vasseur@gustaveroussy.fr, Fachinetti, Francesco3 (AUTHOR) francesco.fachinetti@gustaveroussy.fr, Boilève, Alice1,4 (AUTHOR) cristina.smolenschi@gustaveroussy.fr, Smolenschi, Cristina1,5 (AUTHOR) anthony.tarabay@gustaveroussy.fr, Tarabay, Anthony1 (AUTHOR) leony.antoun@gustaveroussy.fr, Antoun, Leony1 (AUTHOR) audrey.perret@gustaveroussy.fr, Perret, Audrey1 (AUTHOR) alinacristina.fuerea@gustaveroussy.fr, Fuerea, Alina1 (AUTHOR) thomas.pudlarz@gustaveroussy.fr, Pudlarz, Thomas1 (AUTHOR) valerie.boige@gustaveroussy.fr, Boige, Valérie1 (AUTHOR) antoine.hollebecque@gustaveroussy.fr, Hollebecque, Antoine1,5 (AUTHOR) michel.ducreux@gustaveroussy.fr, Ducreux, Michel1,4 (AUTHOR)
Publikováno v:
Cancers. Sep2023, Vol. 15 Issue 18, p4446. 14p.
Publikováno v:
Clinical Trials Week; 10/31/2024, p498-498, 1p